serw-MX  [xml]  
 


    
 DeCS Categories

C10 Nervous System Diseases .
C10.228 Central Nervous System Diseases .
C10.228.140 Brain Diseases .
C10.228.140.300 Cerebrovascular Disorders .
C10.228.140.300.535 Intracranial Hemorrhages .
C10.228.140.300.535.625 Pituitary Apoplexy .
C10.228.140.300.775 Stroke .
C10.228.140.617 Hypothalamic Diseases .
C10.228.140.617.738 Pituitary Diseases .
C10.228.140.617.738.350 Pituitary Apoplexy .
C14 Cardiovascular Diseases .
C14.907 Vascular Diseases .
C14.907.253 Cerebrovascular Disorders .
C14.907.253.573 Intracranial Hemorrhages .
C14.907.253.573.600 Pituitary Apoplexy .
C14.907.253.855 Stroke .
C19 Endocrine System Diseases .
C19.700 Pituitary Diseases .
C19.700.725 Pituitary Apoplexy .
D02 Organic Chemicals .
D02.355 Ethers .
D02.355.291 Ethers, Cyclic .
D02.355.291.852 Oxepins .
D02.355.291.852.500 Doxepin .
D03 Heterocyclic Compounds .
D03.633 Heterocyclic Compounds, Fused-Ring .
D03.633.300 Heterocyclic Compounds, 3-Ring .
D03.633.300.382 Dibenzoxepins .
D03.633.300.382.393 Doxepin .
D08 Enzymes and Coenzymes .
D08.811 Enzymes .
D08.811.277 Hydrolases .
D08.811.277.656 Peptide Hydrolases .
D08.811.277.656.262 Cysteine Proteases .
D08.811.277.656.262.500 Cysteine Endopeptidases .
D08.811.277.656.262.500.126 Caspases .
D08.811.277.656.262.500.126.350 Caspases, Effector .
D08.811.277.656.262.500.126.350.300 Caspase 3 .
D08.811.277.656.300 Endopeptidases .
D08.811.277.656.300.200 Cysteine Endopeptidases .
D08.811.277.656.300.200.126 Caspases .
D08.811.277.656.300.200.126.350 Caspases, Effector .
D08.811.277.656.300.200.126.350.300 Caspase 3 .
D12 Amino Acids, Peptides, and Proteins .
D12.644 Peptides .
D12.644.360 Intracellular Signaling Peptides and Proteins .
D12.644.360.075 Apoptosis Regulatory Proteins .
D12.644.360.075.405 Caspases .
D12.644.360.075.405.350 Caspases, Effector .
D12.644.360.075.405.350.300 Caspase 3 .
D12.776 Proteins .
D12.776.070 Apoproteins .
D12.776.476 Intracellular Signaling Peptides and Proteins .
D12.776.476.075 Apoptosis Regulatory Proteins .
D12.776.476.075.405 Caspases .
D12.776.476.075.405.350 Caspases, Effector .
D12.776.476.075.405.350.300 Caspase 3 .
G04 Cell Physiological Phenomena .
G04.146 Cell Death .
G04.146.160 Apoptosis .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Stroke .
CVA (Cerebrovascular Accident) .
Cerebrovascular Accident, Acute .
Cerebrovascular Stroke .
Stroke, Acute .
Acute Cerebrovascular Accident .
Acute Cerebrovascular Accidents .
Acute Stroke .
Acute Strokes .
Apoplexy, Cerebrovascular .
Brain Vascular Accident .
Brain Vascular Accidents .
CVAs (Cerebrovascular Accident) .
Cerebral Strokes .
Cerebrovascular Accidents .
Cerebrovascular Accidents, Acute .
Cerebrovascular Strokes .
Stroke, Cerebral .
Stroke, Cerebrovascular .
Strokes .
Strokes, Acute .
Strokes, Cerebral .
Strokes, Cerebrovascular .
Vascular Accidents, Brain .
Apoplexy .
Cerebral Stroke .
Cerebrovascular Accident .
Cerebrovascular Apoplexy .
Vascular Accident, Brain .
A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810) .
1.00
162878121
 
Pituitary Apoplexy .
Apoplexy, Pituitary .
The sudden loss of blood supply to the PITUITARY GLAND, leading to tissue NECROSIS and loss of function (PANHYPOPITUITARISM). The most common cause is hemorrhage or INFARCTION of a PITUITARY ADENOMA. It can also result from acute hemorrhage into SELLA TURCICA due to HEAD TRAUMA; INTRACRANIAL HYPERTENSION; or other acute effects of central nervous system hemorrhage. Clinical signs include severe HEADACHE; HYPOTENSION; bilateral visual disturbances; UNCONSCIOUSNESS; and COMA. .
0.69
30693
 
Caspase 3 .
Apopain .
Caspase-3 .
Pro-Caspase-3 .
Procaspase-3 .
Pro Caspase 3 .
Procaspase 3 .
CASP3 .
A short pro-domain caspase that plays an effector role in APOPTOSIS. It is activated by INITIATOR CASPASES such as CASPASE 9. Isoforms of this protein exist due to multiple alternative splicing of its MESSENGER RNA. .
0.61
927382
 
Apoproteins .
Apoprotein .
The protein components of a number of complexes, such as enzymes (APOENZYMES), ferritin (APOFERRITINS), or lipoproteins (APOLIPOPROTEINS). .
0.57
155375
 
Apoptosis .
Apoptosis, Extrinsic Pathway .
Apoptosis, Intrinsic Pathway .
Programmed Cell Death, Type I .
Apoptoses, Extrinsic Pathway .
Apoptoses, Intrinsic Pathway .
Extrinsic Pathway Apoptoses .
Extrinsic Pathway Apoptosis .
Intrinsic Pathway Apoptoses .
Intrinsic Pathway Apoptosis .
Cell Death, Programmed .
One of the mechanisms by which CELL DEATH occurs (compare with NECROSIS and AUTOPHAGOCYTOSIS). Apoptosis is the mechanism responsible for the physiological deletion of cells and appears to be intrinsically programmed. It is characterized by distinctive morphologic changes in the nucleus and cytoplasm, chromatin cleavage at regularly spaced sites, and the endonucleolytic cleavage of genomic DNA; (DNA FRAGMENTATION); at internucleosomal sites. This mode of cell death serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. .
0.56
1027229592
 
Doxepin .
Apo-Doxepin .
Aponal .
Deptran .
Desidox .
Doneurin .
Doxepia .
Doxepin Hydrochloride .
Doxepin Hydrochloride, Cis-Trans Isomer Mixture (approximately 1:5) .
Doxepin beta .
Doxepin-RPh .
Espadox .
Mareen .
Novo-Doxepin .
Prudoxin .
Quitaxon .
Sinequan .
Sinquan .
Xepin .
Zonalon .
Apo Doxepin .
ApoDoxepin .
Doxepin RPh .
Hydrochloride, Doxepin .
Novo Doxepin .
A dibenzoxepin tricyclic compound. It displays a range of pharmacological actions including maintaining adrenergic innervation. Its mechanism of action is not fully understood, but it appears to block reuptake of monoaminergic neurotransmitters into presynaptic terminals. It also possesses anticholinergic activity and modulates antagonism of histamine H(1)- and H(2)-receptors. .
0.55
8798